These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 6832563)

  • 1. Antibiotics and renal tubular damage in cirrhosis.
    Guarnieri GF; Galli G; Ianche M; Lin S
    Gastroenterology; 1983 May; 84(5 Pt 1):1081-3. PubMed ID: 6832563
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibiotics and renal tubular damage in cirrhosis.
    Gastroenterology; 1983 Feb; 84(2):444. PubMed ID: 6336712
    [No Abstract]   [Full Text] [Related]  

  • 3. [Tubular interstitial disorders in the nephrotoxic action of antibiotics].
    Potapova AV; Dzgoeva FU; Kutyrina IM; Zozulia OV; Okunev DIu; Milovanov IuS
    Urol Nefrol (Mosk); 1995; (3):11-4. PubMed ID: 7618213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aminoglycoside nephrotoxicity in cirrhosis. Value of urinary beta 2-microglobulin to discriminate functional renal failure from acute tubular damage.
    Cabrera J; Arroyo V; Ballesta AM; Rimola A; Gual J; Elena M; Rodes J
    Gastroenterology; 1982 Jan; 82(1):97-105. PubMed ID: 6171479
    [No Abstract]   [Full Text] [Related]  

  • 5. [Acute renal insufficiency and nephrotoxic substances].
    Martínez Vea A
    Med Clin (Barc); 1987 Jan; 88(3):103-6. PubMed ID: 3821272
    [No Abstract]   [Full Text] [Related]  

  • 6. Tubular disorders in low birth weight neonates after prolonged antibiotic treatment.
    Giapros VI; Papadimitriou FK; Andronikou SK
    Neonatology; 2007; 91(2):140-4. PubMed ID: 17344665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal tubular damage without glomerular damage after cytotoxic drugs and aminoglycosides.
    Fleming JJ; Child JA; Cooper EH; Hay AM; Morgan DB; Parapia L
    Biomedicine; 1980 Dec; 33(8):251-4. PubMed ID: 7011432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary casts as an indicator of renal tubular damage in patients receiving aminoglycosides.
    Schentag JJ; Gengo FM; Plaut ME; Danner D; Mangione A; Jusko WJ
    Antimicrob Agents Chemother; 1979 Oct; 16(4):468-74. PubMed ID: 518076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of urinary N-acetyl-b-D-glucosaminidase in adult patients with cystic fibrosis: before, during and after treatment with intravenous antibiotics.
    Etherington C; Bosomworth M; Clifton I; Peckham DG; Conway SP
    J Cyst Fibros; 2007 Jan; 6(1):67-73. PubMed ID: 16844430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and pathophysiologic aspects of aminoglycoside nephrotoxicity.
    Humes HD; Weinberg JM; Knauss TC
    Am J Kidney Dis; 1982 Jul; 2(1):5-29. PubMed ID: 7048901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for the development of renal dysfunction in hospitalized patients with cirrhosis.
    Hampel H; Bynum GD; Zamora E; El-Serag HB
    Am J Gastroenterol; 2001 Jul; 96(7):2206-10. PubMed ID: 11467654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glomerular nephrotoxicity of aminoglycosides.
    Martínez-Salgado C; López-Hernández FJ; López-Novoa JM
    Toxicol Appl Pharmacol; 2007 Aug; 223(1):86-98. PubMed ID: 17602717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aminoglycoside toxicity and relation to dose regimen.
    Barclay ML; Begg EJ
    Adverse Drug React Toxicol Rev; 1994; 13(4):207-34. PubMed ID: 7734640
    [No Abstract]   [Full Text] [Related]  

  • 14. [Mechanisms of renal tubular damages by nephrotoxic agents].
    Ueda T
    Nihon Hinyokika Gakkai Zasshi; 1989; 80(13 Suppl):1870-2. PubMed ID: 2485843
    [No Abstract]   [Full Text] [Related]  

  • 15. Re: Hempel et al.--Risk factors for renal dysfunction in hospitalized cirrhotic patients.
    Amiot X; Grangé JD
    Am J Gastroenterol; 2002 May; 97(5):1263-4. PubMed ID: 12014741
    [No Abstract]   [Full Text] [Related]  

  • 16. [The effect of aminoglycosides on the proximal tubules in man].
    Mondorf AW; Breier J; Zegelman M; Müller H
    Adv Clin Pharmacol; 1978; 15():101-10. PubMed ID: 676868
    [No Abstract]   [Full Text] [Related]  

  • 17. [Aminoglycosides, risk factors and neonatal kidney].
    Khoory BJ; Fanos V; Dall'Agnola A; Cataldi L
    Pediatr Med Chir; 1996; 18(5):495-9. PubMed ID: 9053889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aminosidine and renal glycosuria.
    Kirachaiwanich C; Sitprija V
    J Med Assoc Thai; 1972 Jul; 55(7):430-3. PubMed ID: 5052584
    [No Abstract]   [Full Text] [Related]  

  • 19. Renal impairment in cystic fibrosis patients due to repeated intravenous aminoglycoside use.
    Al-Aloul M; Miller H; Alapati S; Stockton PA; Ledson MJ; Walshaw MJ
    Pediatr Pulmonol; 2005 Jan; 39(1):15-20. PubMed ID: 15521084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic-related renal failure and cystic fibrosis.
    Kennedy SE; Henry RL; Rosenberg AR
    J Paediatr Child Health; 2005 Jul; 41(7):382-3. PubMed ID: 16014148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.